Your browser doesn't support javascript.
loading
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go.
Gajjela, Harini; Kela, Iljena; Kakarala, Chandra L; Hassan, Mohammad; Belavadi, Rishab; Gudigopuram, Sri Vallabh Reddy; Raguthu, Ciri C; Modi, Srimy; Sange, Ibrahim.
Afiliação
  • Gajjela H; Research, Our Lady of Fatima University College of Medicine, Valenzuela, PHL.
  • Kela I; Family Medicine, Jagiellonian University Medical College, Krakow, POL.
  • Kakarala CL; Internal Medicine, Jawaharlal Institute of Post-Graduate Medical Education and Research (JIPMER), Pondicherry, IND.
  • Hassan M; Internal Medicine, Mohiuddin Islamic Medical College, Mirpur, PAK.
  • Belavadi R; Surgery, Jawaharlal Institute of Post-Graduate Medical Education and Research (JIPMER), Pondicherry, IND.
  • Gudigopuram SVR; Research, Our Lady of Fatima University College of Medicine, Valenzuela, PHL.
  • Raguthu CC; Research, Tianjin Medical University, Tianjin, CHN.
  • Modi S; Research, K. J. Somaiya Medical College, Mumbai, IND.
  • Sange I; Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cureus ; 13(12): e20359, 2021 Dec.
Article em En | MEDLINE | ID: mdl-35028235
Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood pressure, dyspnea, fatigue, palpitations, etc. This article provided a brief overview of the clinical syndrome of heart failure; its epidemiology, risk factors, symptoms, and staging; and the mechanisms involved in disease progression. This article also described several landmark trials in heart failure that tested the efficacy of first-line drugs such as beta-blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and the latest drugs in the field of heart failure: angiotensin receptor neprilysin inhibitors. Most studies described in this article were guideline-setting trials that revolutionized the practice of medicine and cardiology.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article